ClinicalTrials.Veeva

Menu

Rectal Spacers Use in Prostate Cancer Radiation Therapy

P

Princeton ProCure management, LLC.

Status

Enrolling

Conditions

Prostate Cancer

Treatments

Device: SpaceOAR Vue
Device: BioProtect Balloon Implant System

Study type

Interventional

Funder types

Other

Identifiers

NCT06594887
1378387

Details and patient eligibility

About

This prospective, 2-arm clinical trial aims to evaluate the use of rectal spacers in patients with localized prostate cancer scheduled for Proton Beam Therapy (PBT). Up to 50 subjects will be enrolled in this study.

Study visits will include screening, spacer placement, treatment planning, end-of-treatment assessment, and follow-up visits at 1, 3, and 6 months.

Enrollment

50 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  1. Subjects greater than 18 years old with prostate cancer
  2. Subjects must have histologically confirmed adenocarcinoma of the prostate with biopsy taken within 12 months and must be planned to undergo proton beam therapy with rectal spacer
  3. Subjects must have clinical stage T1-T3 with no posterior extra capsular extension of the prostate cancer
  4. PSA less than or equal to 20 ng/mL
  5. Gleason Score less than or equal to 7
  6. Capacity to comprehend and readiness to sign a written informed consent form

Exclusion Criteria

  1. Planned Pelvic lymph node radiotherapy.
  2. Metastatic disease.
  3. Prior local prostate cancer therapy
  4. Active Inflammatory bowel disease requiring treatment with steroids.
  5. Prior radical prostatectomy.
  6. Active urinary tract infection.
  7. Acute or chronic inflammation or infection of the prostate.

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

SpaceOAR Vue
Experimental group
Treatment:
Device: SpaceOAR Vue
BioProtect Balloon Implant System
Experimental group
Treatment:
Device: BioProtect Balloon Implant System

Trial contacts and locations

1

Loading...

Central trial contact

Heba Darwish; Edward Soffen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems